Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,372 | 190 | 93.4% |
| Travel and Lodging | $238.25 | 1 | 5.1% |
| Education | $70.95 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $965.27 | 50 | $0 (2024) |
| Boston Scientific Corporation | $690.54 | 22 | $0 (2020) |
| Gilead Sciences, Inc. | $647.16 | 25 | $0 (2024) |
| PFIZER INC. | $463.09 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $248.80 | 13 | $0 (2024) |
| Echosens North America, Inc. | $238.25 | 1 | $0 (2019) |
| Celgene Corporation | $233.51 | 19 | $0 (2023) |
| Romark Laboratories, LC | $208.46 | 2 | $0 (2018) |
| Covidien LP | $144.51 | 2 | $0 (2019) |
| Cook Medical LLC | $128.57 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $719.22 | 33 | ABBVIE INC. ($226.14) |
| 2023 | $755.29 | 32 | AbbVie Inc. ($222.82) |
| 2022 | $805.98 | 46 | ABBVIE INC. ($171.87) |
| 2021 | $366.62 | 19 | Gilead Sciences, Inc. ($134.21) |
| 2020 | $84.79 | 4 | Boston Scientific Corporation ($49.00) |
| 2019 | $892.86 | 17 | Boston Scientific Corporation ($258.19) |
| 2018 | $494.03 | 21 | Boston Scientific Corporation ($226.84) |
| 2017 | $562.30 | 21 | BOSTON SCIENTIFIC CORPORATION ($156.51) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Gastroenterology | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.81 | General |
| 10/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.58 | General |
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.23 | General |
| 07/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.83 | General |
| 07/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $50.95 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.89 | General |
| 06/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Rare Disease | ||||||
| 06/14/2024 | 3-D Matrix, Inc. | — | Food and Beverage | In-kind items and services | $47.13 | General |
| 06/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Immunology | ||||||
| 04/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 440 | 641 | $402,855 | $58,306 |
| 2022 | 10 | 437 | 639 | $320,624 | $57,502 |
| 2021 | 11 | 446 | 653 | $332,115 | $67,792 |
| 2020 | 10 | 314 | 485 | $200,381 | $40,637 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 136 | $24,752 | $12,355 | 49.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 50 | 50 | $90,650 | $8,244 | 9.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 56 | $9,576 | $5,582 | 58.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 46 | 163 | $20,212 | $5,316 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $12,276 | $5,241 | 42.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 32 | $10,656 | $4,650 | 43.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 65 | 66 | $78,474 | $4,606 | 5.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 55 | 55 | $88,825 | $4,518 | 5.1% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 21 | $29,274 | $3,981 | 13.6% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $38,160 | $3,813 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 161 | $29,302 | $14,083 | 48.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 74 | $12,654 | $6,442 | 50.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 35 | $11,655 | $5,879 | 50.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 49 | 50 | $80,750 | $5,854 | 7.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $13,671 | $5,763 | 42.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 27 | 28 | $50,764 | $5,058 | 10.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 57 | 60 | $71,340 | $4,579 | 6.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 46 | 140 | $17,360 | $4,415 | 25.4% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 22 | $30,668 | $4,240 | 13.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $2,460 | $1,190 | 48.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 160 | $29,120 | $13,863 | 47.6% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2021 | 12 | 12 | $21,072 | $9,707 | 46.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 54 | 54 | $15,066 | $6,728 | 44.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 32 | 32 | $58,016 | $6,641 | 11.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 72 | $12,312 | $6,362 | 51.7% |
About Dr. David Chung, MD
Dr. David Chung, MD is a Gastroenterology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851362974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Chung, MD has received a total of $4,681 in payments from pharmaceutical and medical device companies, with $719.22 received in 2024. These payments were reported across 193 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,372).
As a Medicare-enrolled provider, Chung has provided services to 1,637 Medicare beneficiaries, totaling 2,418 services with total Medicare billing of $224,237. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Torrance, CA
- Active Since 01/27/2006
- Last Updated 09/26/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1851362974
Products in Payments
- XELJANZ (Drug) $463.09
- RINVOQ (Biological) $377.84
- STELARA (Biological) $248.80
- Fibroscan (Device) $238.25
- ZEPOSIA (Drug) $233.51
- Alinia Tablets 500mg 30 count bottle (Drug) $208.46
- Humira (Biological) $193.66
- GENERAL - BILIARY DEVICES (Device) $153.18
- GENERAL BILIARY DEVICES (Device) $134.04
- ECHOTIP (Device) $128.57
- Da Vinci Surgical System (Device) $127.69
- Sonicision (Device) $121.23
- OCALIVA (Drug) $112.97
- Vemlidy (Drug) $105.58
- SKYRIZI (Biological) $89.79
- GENERAL METAL STENTS GI (Device) $89.60
- GENERAL BILIARY DEVICES (Device) $85.51
- Creon (Drug) $82.78
- DIFICID (Drug) $73.49
- ENTYVIO (Biological) $71.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Torrance
Dr. Tonny Lee, M.d, M.D
Gastroenterology — Payments: $133,902
Sara Kranke
Gastroenterology — Payments: $75,421
Dr. Jennifer Kolb, Md, MD
Gastroenterology — Payments: $60,794
Dr. Jerome Cohen, M.d, M.D
Gastroenterology — Payments: $38,553
Dr. Edward Piken, M.d, M.D
Gastroenterology — Payments: $23,781
Viktor Eysselein, M.d, M.D
Gastroenterology — Payments: $13,509